Your browser doesn't support javascript.
loading
Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting.
Mhibik, Maissa; Gaglione, Erika M; Eik, David; Herrick, John; Le, Janet; Ahn, Inhye E; Chiu, Christopher; Wielgos-Bonvallet, Monica; Hiemstra, Ida H; Breij, Esther C W; Chen, Jenny; Reilly, Edward B; Epling-Burnette, Pearlie K; Szafer-Glusman, Edith; Sun, Clare; Wiestner, Adrian.
Afiliação
  • Mhibik M; Laboratory of Lymphoid Malignancies, Hematology Branch, The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Gaglione EM; Laboratory of Lymphoid Malignancies, Hematology Branch, The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Eik D; Laboratory of Lymphoid Malignancies, Hematology Branch, The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Herrick J; Laboratory of Lymphoid Malignancies, Hematology Branch, The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Le J; Laboratory of Lymphoid Malignancies, Hematology Branch, The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Ahn IE; Laboratory of Lymphoid Malignancies, Hematology Branch, The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Chiu C; Genmab, Princeton, NJ.
  • Wielgos-Bonvallet M; Genmab, Princeton, NJ.
  • Hiemstra IH; Genmab, Utrecht, The Netherlands.
  • Breij ECW; Genmab, Utrecht, The Netherlands.
  • Chen J; Genmab, Princeton, NJ.
  • Reilly EB; AbbVie Inc, North Chicago, IL.
  • Epling-Burnette PK; AbbVie Inc, North Chicago, IL.
  • Szafer-Glusman E; AbbVie Inc, Sunnyvale, CA.
  • Sun C; Laboratory of Lymphoid Malignancies, Hematology Branch, The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Wiestner A; Laboratory of Lymphoid Malignancies, Hematology Branch, The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Blood Adv ; 7(15): 4089-4101, 2023 08 08.
Article em En | MEDLINE | ID: mdl-37219524
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Anticorpos Biespecíficos / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Moldávia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Anticorpos Biespecíficos / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Moldávia